World Protein Therapeutics Market to Reach USD 165 Bln in 2018, Says RNCOS in Its Report Available at MarketPublishers.com
New research report “Global Protein Therapeutics Market Outlook 2018” elaborated by RNCOS E-Services Pvt. Ltd (RNCOS) has been recently published by Market Publishers Ltd. According to the study, the world protein therapeutics market is anticipated to reach USD 165 billion by the end of 2018.
London, UK (PRWEB) January 27, 2014
Since the introduction of the human insulin product, protein-based therapies have captured a significant share of the overall biopharmaceutical market. Protein therapies have gained a good reputation for being an effective clinical method to treat a broad range of different diseases ranging from various types of cancer to metabolic disorders. The US ranks as the leading protein therapeutics market owing to the high levels of product sales. The world protein therapeutics market is expected to have a tremendous growth potential; by the end of 2018, it is anticipated to amount to USD 165 billion, driven primarily by the new product launches. Asian countries are regarded as the most promising protein therapeutics markets due to a large pool of patients, along with constantly rising disposable incomes.
Roche Group, Abbott Laboratories, Eli Lilly & Company, Novo Nordisk, Merck Serono S.A., Johnson & Johnson, Pfizer, Biogen Idec Inc., Amgen Inc. and Sanofi-Aventis are amid the companies accounting for dominant market shares of the global protein therapeutics market.
New research report “Global Protein Therapeutics Market Outlook 2018” elaborated by RNCOS E-Services Pvt. Ltd (RNCOS) has been recently published by Market Publishers Ltd.
Title: Global Protein Therapeutics Market Outlook 2018
Published: January, 2014
Price: US$ 1,800.00
A comprehensive examination of the world protein therapeutics market is provided in the report, together with important data on the industry historical performance and the current market landscape. The research study scrutinizes the current and future revenue generation patterns with respect to the main market segments, contains a prudent analysis of the recent and significant industry developments, covers the drugs in the 3rd phase of the clinical trial and determines their potential. It provides a clear idea of who stands where in the worldwide market for protein therapeutics, reviews the key market players and uncovers details on their performance. The report contains a summary of the prevailing market trends, features the main geographical markets, discloses valuable data on the existing products and, furthermore offers extensive outlook for the overall protein therapeutics market performance through 2018.
- Thorough analysis of the world protein therapeutics market.
- Profound insights into the actual market state as well as important market estimates and values.
- Insightful overview of the major market segments including monoclonal antibodies, erythropoietin, insulin, interferon, human growth hormone, blood clotting factor, follicle stimulating hormone and granulocyte colony stimulating factor.
- Extensive analysis of advanced phase drugs.
- Snapshot of the emerging market trends.
- Comprehensive profiles of the key market participants.
- Forecasts of the future industry performance up to 2018.
More new research reports by the publisher can be found at RNCOS page.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/01/prweb11525189.htm